15 mins., DMG test Disaster Management Group LLC; Biomedomics Inc. Launched a 15-minute screening tool for COVID-19 that can be administered at drive-thru testing sites; the test was developed under license for DMGtest by Biomedomics; test detects both early marker and late marker, IgM/IgG antibodies in human finger-prick or venous blood samples
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.